Company Anavex Life Sciences Corp OTC Bulletin Board
Equities
AVXL
US0327971026
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 13-07-04 | |
Sandra Boenisch
DFI | Director of Finance/CFO | 43 | 15-09-30 |
Edward Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Walter Kaufmann
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-01 |
Stephan Toutain
COO | Chief Operating Officer | - | 18-03-04 |
David Goldberger
LAW | General Counsel | - | Nov. 05 |
Adebayo Laniyonu
PRN | Corporate Officer/Principal | - | 21-05-04 |
Daniel Klamer
PRN | Corporate Officer/Principal | - | 15-08-31 |
Juliana Daley
PRN | Corporate Officer/Principal | 37 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 13-07-04 | |
Tom Skarpelos
FOU | Founder | 57 | 04-01-22 |
Jiong Ma
CHM | Chairman | 60 | 21-05-24 |
Steffen Thomas
BRD | Director/Board Member | 58 | 15-06-14 |
Peter Donhauser
BRD | Director/Board Member | 58 | 17-02-07 |
Director/Board Member | 51 | 18-03-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 82,112,511 | 79,530,715 ( 96.86 %) | 0 | 96.86 % |
Company contact information
Anavex Life Sciences Corp.
630 5th Avenue 20th floor
10111, New York
+844 689 3939
http://www.anavex.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-3.10% | 102B | |
+2.11% | 96.37B | |
-1.80% | 21.37B | |
-17.75% | 20.92B | |
-6.91% | 18.64B | |
-42.00% | 16.4B | |
-28.19% | 13.53B | |
+0.18% | 13.28B | |
+19.90% | 10.85B |
- Stock Market
- Equities
- AVXL Stock
- AVXL Stock
- Company Anavex Life Sciences Corp